Literature DB >> 23500884

Anti-Helicobacter pylori compounds from the ethanol extracts of Geranium wilfordii.

Xi-Quan Zhang1, Hong-Mei Gu, Xin-Zhu Li, Zhong-Nan Xu, Yu-Sheng Chen, Yang Li.   

Abstract

UNLABELLED: ETHNOPHARMOCOLOGICAL RELEVANCE: Geranium wilfordii Maxim has been extensively used in Chinese Herbal Medicine for treating gastrointestinal disorders, diarrhea and dysentery. In the current study we aimed to investigate the anti-Helicobacter pylori activity of ethanol extracts of Geranium wilfordii Maxim and its main active compounds, corilagin and 1,2,3,6-tetra-O-galloyl-β-D-glucose.
MATERIALS AND METHODS: The plant materials were extracted three times with ethanol and the concentrated filtrate was successively fractioned into chloroform, ethyl acetate, and n-BuOH-soluble portions which were examined in vitro for the anti-Helicobacter. pylori activity. Employing a standard strain and five clinical isolates of Helicobacter pylori, the extract, fractions and compounds of Geranium wilfordii Maxim were assessed in vitro.
RESULTS: The ethanol fraction, ethyl acetate fraction, corilagin, and 1,2,3,6-tetra-O-galloyl-β-D-glucose were found to be strongly inhibitory to Helicobacter. pylori (MICs: 40, 30, 4, and 8μg/ml respectively).
CONCLUSIONS: The results of the present study showed that the ethanol and the ethyl acetate extracts from Geranium wilfordii Maxim displayed as well the most significant inhibition to the growth of Helicobacter. pylori, of which corilagin and 1,2,3,6-tetra-O-galloyl-β-D-glucose have been identified main anti-Helicobacter pylori active constituents.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500884     DOI: 10.1016/j.jep.2013.02.032

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  9 in total

Review 1.  Innovative Perspectives of Integrated Chinese Medicine on H. pylori.

Authors:  Hui Ye; Zong-Ming Shi; Yao Chen; Jing Yu; Xue-Zhi Zhang
Journal:  Chin J Integr Med       Date:  2018-06-08       Impact factor: 1.978

2.  Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.

Authors:  Fan Yang; Yao Wang; Gang Li; Juan Xue; Zhi-Lin Chen; Feng Jin; Lei Luo; Xuan Zhou; Qian Ma; Xin Cai; Hua-Rong Li; Lei Zhao
Journal:  Br J Pharmacol       Date:  2018-01-25       Impact factor: 8.739

Review 3.  Medicinal plant activity on Helicobacter pylori related diseases.

Authors:  Yuan-Chuen Wang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 4.  Overview of the phytomedicine approaches against Helicobacter pylori.

Authors:  Filipa F Vale; Mónica Oleastro
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

5.  Chemical Constituents of Cymbocarpum erythraeum (DC.) Boiss., and Evaluation of Its Anti-Helicobacter pylori Activity.

Authors:  Samaneh Heidari; Azadeh Manayi; Soodabeh Saeidnia; Hossein Mighani; Hamid Reza Monsef Esfahani; Ahmad Reza Gohari; William N Setzer
Journal:  Turk J Pharm Sci       Date:  2018-04-02

6.  Enhanced stability and antibacterial efficacy of a traditional Chinese medicine-mediated silver nanoparticle delivery system.

Authors:  Wenjie Sun; Ding Qu; Yihua Ma; Yan Chen; Congyan Liu; Jing Zhou
Journal:  Int J Nanomedicine       Date:  2014-11-26

7.  The protective effects of polysaccharide extract from Xin-Ji-Er-Kang formula on Ang II-induced HUVECs injury, L-NAME-induced hypertension and cardiovascular remodeling in mice.

Authors:  Ling Ding; Pan Cheng; Li Wang; Juan Hu; Yong-Xue Zhang; Guo-Wei Cai; Guang-Yao Huang; Shan Gao
Journal:  BMC Complement Altern Med       Date:  2019-06-13       Impact factor: 3.659

Review 8.  Plants against Helicobacter pylori to combat resistance: An ethnopharmacological review.

Authors:  Doha Abou Baker
Journal:  Biotechnol Rep (Amst)       Date:  2020-05-21

Review 9.  Phytochemicals in Helicobacter pylori Infections: What Are We Doing Now?

Authors:  Bahare Salehi; Farukh Sharopov; Miquel Martorell; Jovana Rajkovic; Adedayo Oluwaseun Ademiluyi; Mehdi Sharifi-Rad; Patrick Valere Tsouh Fokou; Natália Martins; Marcello Iriti; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.